Company profile
Allena Pharmaceuticals company profile
Allena Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class, oral biologic therapeutics to treat patients with rare and severe metabolic and kidney disorders. Allena’s lead product candidate, reloxaliase, is currently being evaluated in a pivotal Phase 3 clinical program for the treatment of enteric hyperoxaluria, a metabolic disorder characterized by markedly elevated urinary oxalate levels and commonly associated with kidney stones, chronic kidney disease and other serious kidney disorders.
Business identity
- Website
- http://www.allenapharma.com
- Contact email
- [email protected]
- Phone number
- +1-617-467-4577
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00051-00100 employees
- Revenue range
- $1K+
- Founded
- 2011-01-01
Headquarters
- Headquarters
- Calumet City, Illinois, United States
- Postal code
- 02462
- Country code
- US
- Continent
- North America